In a nutshell This study examined the benefit of combining silodosin (Rapaflo) with propiverine (Mictonorm) in reducing urinary symptoms due to benign prostatic hyperplasia (BPH). Authors reported greater overall improvements when both therapies were combined. Some background Men with BPH often experience urinary symptoms that can...
Read More
In a nutshell This study evaluated the effectiveness of Flowens (a cranberry fruit powder) as an alternative treatment for benign prostatic hyperplasia (BPH). Researchers report preliminary evidence that Flowens can reduce BPH-related urinary symptoms. Some background BPH can lead to bothersome urinary symptoms that can impact quality of life. The...
Read More
In a nutshell This study evaluated the safety and effectiveness of silodosin (Rapaflo) in treating urinary symptoms among men with benign prostatic hyperplasia (BPH). Researchers concluded that silodosin is well-tolerated and significantly improves a range of urinary symptoms in most men. Some background Drugs that are commonly prescribed for...
Read More
In a nutshell This study examined prostate artery embolization as a minimally invasive procedure to reduce prostate size in older men with benign prostatic hyperplasia (BPH). The researchers concluded that prostate artery embolization is a safe and effective treatment option for younger as well as older men wit BPH. Some background BPH can lead...
Read More
In a nutshell This study reviewed the effects of combined α-blocker and anticholinergic therapy on urinary symptoms in men with benign prostatic hyperplasia (BPH). Some background Men with enlarged prostates often experience bothersome urinary symptoms. These may include increased frequency or urgency of urination, frequently waking up at...
Read More
